156 related articles for article (PubMed ID: 24115432)
1. Genetics. GWAS to therapy by genome edits?
Hardison RC; Blobel GA
Science; 2013 Oct; 342(6155):206-7. PubMed ID: 24115432
[No Abstract] [Full Text] [Related]
2. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.
Bauer DE; Kamran SC; Lessard S; Xu J; Fujiwara Y; Lin C; Shao Z; Canver MC; Smith EC; Pinello L; Sabo PJ; Vierstra J; Voit RA; Yuan GC; Porteus MH; Stamatoyannopoulos JA; Lettre G; Orkin SH
Science; 2013 Oct; 342(6155):253-7. PubMed ID: 24115442
[TBL] [Abstract][Full Text] [Related]
3. Developmental biology. From genetic association to genetic switch.
Michelson AM
Science; 2008 Dec; 322(5909):1803-4. PubMed ID: 19095932
[No Abstract] [Full Text] [Related]
4. Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.
Macari ER; Schaeffer EK; West RJ; Lowrey CH
Blood; 2013 Jan; 121(5):830-9. PubMed ID: 23223429
[TBL] [Abstract][Full Text] [Related]
5. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
[TBL] [Abstract][Full Text] [Related]
6. Update on fetal hemoglobin gene regulation in hemoglobinopathies.
Bauer DE; Orkin SH
Curr Opin Pediatr; 2011 Feb; 23(1):1-8. PubMed ID: 21157349
[TBL] [Abstract][Full Text] [Related]
7. Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells.
Grevet JD; Lan X; Hamagami N; Edwards CR; Sankaranarayanan L; Ji X; Bhardwaj SK; Face CJ; Posocco DF; Abdulmalik O; Keller CA; Giardine B; Sidoli S; Garcia BA; Chou ST; Liebhaber SA; Hardison RC; Shi J; Blobel GA
Science; 2018 Jul; 361(6399):285-290. PubMed ID: 30026227
[TBL] [Abstract][Full Text] [Related]
8. Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus.
Jawaid K; Wahlberg K; Thein SL; Best S
Blood Cells Mol Dis; 2010 Aug; 45(2):140-6. PubMed ID: 20542454
[TBL] [Abstract][Full Text] [Related]
9. Strict in vivo specificity of the
Smith EC; Luc S; Croney DM; Woodworth MB; Greig LC; Fujiwara Y; Nguyen M; Sher F; Macklis JD; Bauer DE; Orkin SH
Blood; 2016 Nov; 128(19):2338-2342. PubMed ID: 27707736
[TBL] [Abstract][Full Text] [Related]
10. Flicking the switch: adult hemoglobin expression in erythroid cells derived from cord blood and human induced pluripotent stem cells.
Cantú I; Philipsen S
Haematologica; 2014 Nov; 99(11):1647-9. PubMed ID: 25420279
[No Abstract] [Full Text] [Related]
11. Hemoglobinopathies in the Fetal Position.
Pasricha SR; Drakesmith H
N Engl J Med; 2018 Oct; 379(17):1675-1677. PubMed ID: 30354961
[No Abstract] [Full Text] [Related]
12. Transcriptional mechanisms underlying hemoglobin synthesis.
Katsumura KR; DeVilbiss AW; Pope NJ; Johnson KD; Bresnick EH
Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a015412. PubMed ID: 23838521
[TBL] [Abstract][Full Text] [Related]
13. Multiple physical stresses induce γ-globin gene expression and fetal hemoglobin production in erythroid cells.
Schaeffer EK; West RJ; Conine SJ; Lowrey CH
Blood Cells Mol Dis; 2014 Apr; 52(4):214-24. PubMed ID: 24314748
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A.
Lulli V; Romania P; Morsilli O; Cianciulli P; Gabbianelli M; Testa U; Giuliani A; Marziali G
PLoS One; 2013; 8(4):e60436. PubMed ID: 23593217
[TBL] [Abstract][Full Text] [Related]
15. Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL.
Trakarnsanga K; Wilson MC; Lau W; Singleton BK; Parsons SF; Sakuntanaga P; Kurita R; Nakamura Y; Anstee DJ; Frayne J
Haematologica; 2014 Nov; 99(11):1677-85. PubMed ID: 25107887
[TBL] [Abstract][Full Text] [Related]
16. Medicine. Sickle cell disease at 100 years.
Orkin SH; Higgs DR
Science; 2010 Jul; 329(5989):291-2. PubMed ID: 20647458
[No Abstract] [Full Text] [Related]
17. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
[TBL] [Abstract][Full Text] [Related]
18. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
[TBL] [Abstract][Full Text] [Related]
19. Point mutations or polymorphisms? A sequence analysis of the enhancer 3' to the A gamma-globin gene.
Cohen CJ; Penny L; Forget BG
Prog Clin Biol Res; 1989; 316B():395-401. PubMed ID: 2482504
[No Abstract] [Full Text] [Related]
20. Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies.
Liu B; Brendel C; Vinjamur DS; Zhou Y; Harris C; McGuinness M; Manis JP; Bauer DE; Xu H; Williams DA
Mol Ther; 2022 Aug; 30(8):2693-2708. PubMed ID: 35526095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
